<html xmlns="http://www.w3.org/1999/xhtml" xmlns="http://www.w3.org/1999/xhtml">
 <head xmlns="http://www.w3.org/1999/xhtml">
 <title xmlns="http://www.w3.org/1999/xhtml"></title>
 </head>
 <body xmlns="http://www.w3.org/1999/xhtml">
 
 Levi &amp; Korsinsky, LLP announces it has commenced an investigation of 
 United States Steel Corporation ("United States Steel") X 
 concerning possible violations of federal securities laws. On April 25, 
 2017, United States Steel reported a first quarter 2017 net loss of $180 
 million, including an unfavorable adjustment of $35 million associated 
 with a loss on the shutdown of certain tubular assets. To obtain 
 additional information, go to:
 
 
 <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fzlk.9nl.com%2Fsteel-x&amp;esheet=51548462&amp;newsitemid=20170426006821&amp;lan=en-US&amp;anchor=http%3A%2F%2Fzlk.9nl.com%2Fsteel-x&amp;index=1&amp;md5=718bded5b659179ab13dcd32522395da" rel="nofollow" rel="nofollow">http://zlk.9nl.com/steel-x</a>
 
 
 or contact Joseph E. Levi, Esq. either via email at <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:jlevi@levikorsinsky.com" rel="nofollow" rel="nofollow">jlevi@levikorsinsky.com</a> 
 or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
 
 
 Levi &amp; Korsinsky is a national firm with offices in New York, 
 Connecticut, California and Washington D.C. The firm's attorneys have 
 extensive expertise in prosecuting securities litigation involving 
 financial fraud, representing investors throughout the nation in 
 securities and shareholder lawsuits. Attorney advertising. Prior results 
 do not guarantee similar outcomes.
 
 
 
 <img xmlns="http://www.w3.org/1999/xhtml" alt="" src="http://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20170426006821r1&amp;sid=benz2&amp;distro=nx&amp;lang=en"></img>View source version on businesswire.com: <a xmlns="http://www.w3.org/1999/xhtml" href="http://www.businesswire.com/news/home/20170426006821/en/" rel="nofollow" rel="nofollow">http://www.businesswire.com/news/home/20170426006821/en/</a></body></html>

Press Releases

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of United States Steel Corporation - United States Steel (NYSE:X)

United States Steel

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of United States Steel Corporation


LJI and RevolKa will Research Nex-gen Vaccine Antigens by using AI-driven Protein Engineering Platform


RevolKa Ltd. (Norio Hamamatsu, President &amp; CEO), a venture-backed biotech company providing a game-changing

La Jolla Institute for Immunology and RevolKa started a Research Collaboration


Striking workers to speak at pension fund meeting with investments in Aimbridge


Dozens of workers at the Hampton Inn &amp; Suites Santa Monica and Courtyard Santa Monica–hotels operated by Aimbridge Hospitality–walked

UNITE HERE Local 11: Workers at Aimbridge-Operated SaMo Hotel Submit Letter to City Attorney, Calling for Investigation Into Hotels&#39; Compliance With Panic Button Law Following Allegations of Sexual Misconduct


With over $2 billion in assets, Texas Partners Bank celebrates 17 years of powering partnerships in Central Texas communities.


Southwest Bancshares, Inc., the bank holding company for Texas Partners Bank, today

Southwest Bancshares, Inc., Announces Texas Partners Bank as the Regional Bank Brand


Prudent financial policies, comprehensive resource planning in district&#39;s new biennial budget cited as foundation of ratings from S&amp;P, Moody&#39;s


A week after its governing board adopted a financially responsible

Two Top Rating Agencies Reaffirm Metropolitan&#39;s Strong Credit Ratings

TYO:4502


− ENTYVIO is Now Available in the U.S. in Both IV and Subcutaneous Administrations for Maintenance Treatment of Adults with Moderately to Severely Active Ulcerative Colitis or Crohn&#39;s Disease


Takeda ((

U.S. FDA Approves Subcutaneous Administration of Takeda&#39;s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn&#39;s Disease

MATV


Mativ Holdings, Inc. (NYSE:MATV) today announced it will release first quarter 2024 financial results on May 8, 2024, after the market closes.


A conference call to discuss these results has been scheduled for 8:30